Literature DB >> 22265576

Minocycline as potent anticonvulsant in a patient with astrocytoma and drug resistant epilepsy.

M Nowak1, A Strzelczyk, P S Reif, K Schorlemmer, S Bauer, B A Norwood, W H Oertel, F Rosenow, H Strik, H M Hamer.   

Abstract

Minocycline, a tetracycline family antibiotic, is known to inhibit microglial activation and proinflammatory cytokine release in animal models. Experimental data show that these immune processes may play a role in epilepto- and ictogenesis. We present the case of a patient with marked reduction in seizure frequency during minocycline therapy with severe symptomatic epilepsy due to an astrocytoma. Copyright Â
© 2011 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22265576     DOI： 10.1016/j.seizure.2011.12.009

Source DB:  PubMed          Journal:  Seizure        ISSN： 1059-1311            Impact factor:   3.184


  14 in total

1.  Effect of minocycline on pentylenetetrazol-induced chemical kindled seizures in mice.

Authors:  Nooshin Ahmadirad; Amir Shojaei; Mohammad Javan; Mohammad H Pourgholami; Javad Mirnajafi-Zadeh
Journal:  Neurol Sci       Date:  2013-10-15       Impact factor: 3.307

2.  Effective Reduction of Acute Ethanol Withdrawal by the Tetracycline Derivative, Tigecycline, in Female and Male DBA/2J Mice.

Authors:  Joseph M Martinez; Jessica A Groot; David C Curtis; Clayton L Allison; Patrick C Marquardt; Ashley N Holmes; David S Edwards; David R M Trotter; Peter J Syapin; Deborah A Finn; Susan E Bergeson
Journal:  Alcohol Clin Exp Res       Date:  2016-11-14       Impact factor: 3.455

Review 3.  Emerging Role of Microglia-Mediated Neuroinflammation in Epilepsy after Subarachnoid Hemorrhage.

Authors:  Jingxue Liang; Jiahong Deng; Xiaolin Liang; Jun Wang; Kewan Wang; Hongxiao Wang; Dadi Qian; Hao Long; Kaijun Yang; Songtao Qi
Journal:  Mol Neurobiol       Date:  2021-01-26       Impact factor: 5.590

Review 4.  Microglia-Neuron Communication in Epilepsy.

Authors:  Ukpong B Eyo; Madhuvika Murugan; Long-Jun Wu
Journal:  Glia       Date:  2016-05-18       Impact factor: 7.452

Review 5.  Novel frontiers in epilepsy treatments: preventing epileptogenesis by targeting inflammation.

Authors:  Raimondo D'Ambrosio; Clifford L Eastman; Cinzia Fattore; Emilio Perucca
Journal:  Expert Rev Neurother       Date:  2013-06       Impact factor: 4.618

6.  Rapamycin, but not minocycline, significantly alters ultrasonic vocalization behavior in C57BL/6J pups in a flurothyl seizure model.

Authors:  Samantha L Hodges; Paige D Womble; Eliesse M Kwok; Alyssa M Darner; Savannah S Senger; Matthew S Binder; Amanda M Faust; Siena M Condon; Suzanne O Nolan; Saul I Quintero; Joaquin N Lugo
Journal:  Behav Brain Res       Date:  2021-04-25       Impact factor: 3.352

Review 7.  Toward a noncytotoxic glioblastoma therapy: blocking MCP-1 with the MTZ Regimen.

Authors:  Michael E Salacz; Richard E Kast; Najmaldin Saki; Ansgar Brüning; Georg Karpel-Massler; Marc-Eric Halatsch
Journal:  Onco Targets Ther       Date:  2016-04-27       Impact factor: 4.147

Review 8.  What value can TSPO PET bring for epilepsy treatment?

Authors:  Viviane Bouilleret; Stefanie Dedeurwaerdere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-06-12       Impact factor: 9.236

Review 9.  The Role of Neuroinflammation in Post-traumatic Epilepsy.

Authors:  Lei Sun; Wei Shan; Huajun Yang; Ru Liu; Jianping Wu; Qun Wang
Journal:  Front Neurol       Date:  2021-05-28       Impact factor: 4.003

10.  Antidepressant use and risk of epilepsy and seizures in people aged 20 to 64 years: cohort study using a primary care database.

Authors:  Trevor Hill; Carol Coupland; Richard Morriss; Antony Arthur; Michael Moore; Julia Hippisley-Cox
Journal:  BMC Psychiatry       Date:  2015-12-17       Impact factor: 3.630
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.